[Double-blind multicenter trial in general practice on fluphenthixol versus nortriptyline in patients with anxiety-depression-asthenia (the "ADA"-syndrome)].
D000328:Adult; D001007:Anxiety / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy*; D005260:Female; D005475:Flupenthixol / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009440:Neurasthenia / Q000188:drug therapy*; D009661:Nortriptyline / Q000009:adverse effects / Q000627:therapeutic use*; D012737:Sex Factors; D013892:Thioxanthenes / Q000627:therapeutic use*
D013892:Thioxanthenes; D009661:Nortriptyline; D005475:Flupenthixol
Dobbeltblind klinisk multisenterundersøkelse i almenpraksis av flupentixol mot nortriptylin hos pasienter med angst-depresjon-asteni ("ADA-syndromet")